Acid-sensitive lipidated doxorubicin prodrug entrapped in nanoemulsion impairs lung tumor metastasis in a breast cancer model
出版年份 2017 全文链接
标题
Acid-sensitive lipidated doxorubicin prodrug entrapped in nanoemulsion impairs lung tumor metastasis in a breast cancer model
作者
关键词
-
出版物
Nanomedicine
Volume 12, Issue 15, Pages 1751-1765
出版商
Future Medicine Ltd
发表日期
2017-07-13
DOI
10.2217/nnm-2017-0091
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Prevention of Distant Lung Metastasis After Photodynamic Therapy Application in a Breast Cancer Tumor Model
- (2016) João Paulo Figueiró Longo et al. Journal of Biomedical Nanotechnology
- Protective effects of endothelin receptor A and B inhibitors against doxorubicin-induced cardiomyopathy
- (2015) Matthias Schwebe et al. BIOCHEMICAL PHARMACOLOGY
- Lipid prodrug nanocarriers in cancer therapy
- (2015) Simona Mura et al. JOURNAL OF CONTROLLED RELEASE
- Dendritic polymer imaging systems for the evaluation of conjugate uptake and cleavage
- (2015) Harald R. Krüger et al. Nanoscale
- Aluminium-phthalocyanine chloride nanoemulsions for anticancer photodynamic therapy: Development and in vitro activity against monolayers and spheroids of human mammary adenocarcinoma MCF-7 cells
- (2015) Luis Alexandre Muehlmann et al. JOURNAL OF NANOBIOTECHNOLOGY
- First-Line Aldoxorubicin vs Doxorubicin in Metastatic or Locally Advanced Unresectable Soft-Tissue Sarcoma
- (2015) Sant P. Chawla et al. JAMA Oncology
- Dynamic assessment of cell viability, proliferation and migration using real time cell analyzer system (RTCA)
- (2014) Mani Roshan Moniri et al. CYTOTECHNOLOGY
- Imaging of doxorubicin release from theranostic macromolecular prodrugs via fluorescence resonance energy transfer
- (2014) Harald R. Krüger et al. JOURNAL OF CONTROLLED RELEASE
- H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection
- (2014) M. Liang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer
- (2013) D. Alizadeh et al. CANCER RESEARCH
- P-glycoprotein Mediates Drug Resistance via a Novel Mechanism Involving Lysosomal Sequestration
- (2013) Tetsuo Yamagishi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Luminol-based bioluminescence imaging of mouse mammary tumors
- (2013) Hamad S. Alshetaiwi et al. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
- The biophysics and cell biology of lipid droplets
- (2013) Abdou Rachid Thiam et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Changes in Cardiac Biomarkers During Doxorubicin Treatment of Pediatric Patients With High-Risk Acute Lymphoblastic Leukemia: Associations With Long-Term Echocardiographic Outcomes
- (2012) Steven E. Lipshultz et al. JOURNAL OF CLINICAL ONCOLOGY
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial
- (2012) John R Mackey et al. LANCET ONCOLOGY
- Liposome-Encapsulated Doxorubicin Reverses Drug Resistance by Inhibiting P-Glycoprotein in Human Cancer Cells
- (2011) Chiara Riganti et al. MOLECULAR PHARMACEUTICS
- Tumor delivery of macromolecular drugs based on the EPR effect
- (2010) Vladimir Torchilin ADVANCED DRUG DELIVERY REVIEWS
- Development of efficient macromolecular prodrugs derived from dendritic polyglycerol
- (2010) Marcelo Calderón et al. JOURNAL OF CONTROLLED RELEASE
- Inflammatory Breast Cancer—Comparing the Effectivity of Preoperative Docetaxel-Epirubicine Protocol to Conventional Antracycline-Containing Chemotherapy to Achieve Clinical Benefit and Complete Pathological Response
- (2010) Zsolt Horváth et al. PATHOLOGY & ONCOLOGY RESEARCH
- Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
- (2009) Yogeshkumar Malam et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
- (2008) C. Marcela Diaz-Montero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Development of enzymatically cleavable doxorubicin conjugates with polyglycerol
- (2008) M. Calderón et al. JOURNAL OF CONTROLLED RELEASE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started